GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MAF
|
ENSG00000178573.7 | MAF |
NRL
|
ENSG00000129535.13 | NRL |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NRL | hg38_v1_chr14_-_24114913_24115010, hg38_v1_chr14_-_24084625_24084641 | 0.66 | 9.4e-29 | Click! |
MAF | hg38_v1_chr16_-_79599902_79600058 | 0.59 | 3.6e-22 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr16_+_176659 | 71.11 |
ENST00000320868.9
ENST00000397797.1 |
HBA1
|
hemoglobin subunit alpha 1 |
chr14_-_105771405 | 32.19 |
ENST00000641136.1
ENST00000390551.6 |
IGHG3
|
immunoglobulin heavy constant gamma 3 (G3m marker) |
chr11_-_5243644 | 29.41 |
ENST00000643122.1
|
HBD
|
hemoglobin subunit delta |
chr18_+_24113341 | 16.93 |
ENST00000540918.2
|
TTC39C
|
tetratricopeptide repeat domain 39C |
chr6_+_33080445 | 16.78 |
ENST00000428835.5
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
chrX_+_129779930 | 16.75 |
ENST00000356892.4
|
SASH3
|
SAM and SH3 domain containing 3 |
chr12_-_12338674 | 16.55 |
ENST00000545735.1
|
MANSC1
|
MANSC domain containing 1 |
chr5_+_151020438 | 15.56 |
ENST00000622181.4
ENST00000614343.4 ENST00000388825.9 ENST00000521650.5 ENST00000517973.1 |
GPX3
|
glutathione peroxidase 3 |
chr7_-_126533850 | 15.46 |
ENST00000444921.3
|
GRM8
|
glutamate metabotropic receptor 8 |
chr6_+_31615215 | 14.18 |
ENST00000337917.11
ENST00000376059.8 |
AIF1
|
allograft inflammatory factor 1 |
chr19_+_44914247 | 14.09 |
ENST00000588750.5
ENST00000588802.5 |
APOC1
|
apolipoprotein C1 |
chr2_-_210303608 | 13.33 |
ENST00000341685.8
|
MYL1
|
myosin light chain 1 |
chr2_-_178807415 | 13.30 |
ENST00000342992.10
ENST00000460472.6 ENST00000589042.5 ENST00000591111.5 ENST00000360870.10 |
TTN
|
titin |
chr14_-_105743032 | 13.20 |
ENST00000390548.6
ENST00000390549.6 ENST00000390542.6 |
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
chr17_+_1771688 | 12.95 |
ENST00000572048.1
ENST00000573763.1 |
SERPINF1
|
serpin family F member 1 |
chr14_-_106538331 | 12.64 |
ENST00000390624.3
|
IGHV3-48
|
immunoglobulin heavy variable 3-48 |
chr14_+_69398683 | 12.51 |
ENST00000556605.5
ENST00000031146.8 ENST00000336643.10 |
SLC39A9
|
solute carrier family 39 member 9 |
chr14_-_105626066 | 12.50 |
ENST00000641978.1
ENST00000390543.3 |
IGHG4
|
immunoglobulin heavy constant gamma 4 (G4m marker) |
chr11_+_116829898 | 12.32 |
ENST00000227667.8
ENST00000375345.3 |
APOC3
|
apolipoprotein C3 |
chr1_-_56966006 | 11.94 |
ENST00000371237.9
|
C8B
|
complement C8 beta chain |
chr19_+_44914833 | 11.77 |
ENST00000589078.1
ENST00000586638.5 |
APOC1
|
apolipoprotein C1 |
chr12_+_111766887 | 11.59 |
ENST00000416293.7
ENST00000261733.7 |
ALDH2
|
aldehyde dehydrogenase 2 family member |
chr19_+_39406831 | 11.56 |
ENST00000597629.3
ENST00000594442.2 ENST00000594045.2 |
ZFP36
|
ZFP36 ring finger protein |
chrX_+_65488735 | 11.45 |
ENST00000338957.4
|
ZC3H12B
|
zinc finger CCCH-type containing 12B |
chr12_-_70788914 | 11.45 |
ENST00000342084.8
|
PTPRR
|
protein tyrosine phosphatase receptor type R |
chr11_+_116830529 | 11.15 |
ENST00000630701.1
|
APOC3
|
apolipoprotein C3 |
chr19_+_42313374 | 10.97 |
ENST00000598766.1
ENST00000673187.1 |
TMEM145
|
transmembrane protein 145 |
chr19_+_44914588 | 10.74 |
ENST00000592535.6
|
APOC1
|
apolipoprotein C1 |
chr6_-_33080710 | 10.56 |
ENST00000419277.5
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1 |
chr22_+_20774092 | 10.50 |
ENST00000215727.10
|
SERPIND1
|
serpin family D member 1 |
chr10_-_11611754 | 10.04 |
ENST00000609104.5
|
USP6NL
|
USP6 N-terminal like |
chr9_-_90642855 | 9.91 |
ENST00000637905.1
|
DIRAS2
|
DIRAS family GTPase 2 |
chr17_+_1762052 | 9.75 |
ENST00000254722.9
ENST00000576406.5 ENST00000571149.5 |
SERPINF1
|
serpin family F member 1 |
chr11_-_2139382 | 9.63 |
ENST00000416167.7
|
IGF2
|
insulin like growth factor 2 |
chr11_-_5249836 | 9.61 |
ENST00000632727.1
ENST00000330597.5 |
HBG1
|
hemoglobin subunit gamma 1 |
chr14_-_77320855 | 9.61 |
ENST00000556394.2
ENST00000261534.9 |
POMT2
|
protein O-mannosyltransferase 2 |
chr4_+_77605807 | 9.57 |
ENST00000682537.1
|
CXCL13
|
C-X-C motif chemokine ligand 13 |
chr1_-_1358524 | 9.48 |
ENST00000445648.5
ENST00000309212.11 |
MXRA8
|
matrix remodeling associated 8 |
chr1_+_22007450 | 9.23 |
ENST00000400271.2
|
CELA3A
|
chymotrypsin like elastase 3A |
chr2_-_86105839 | 9.12 |
ENST00000263857.11
|
POLR1A
|
RNA polymerase I subunit A |
chr2_-_136116165 | 9.11 |
ENST00000409817.1
|
CXCR4
|
C-X-C motif chemokine receptor 4 |
chr11_-_5254741 | 9.08 |
ENST00000444587.1
ENST00000336906.6 ENST00000642908.1 ENST00000647543.1 |
HBG2
ENSG00000284931.1
|
hemoglobin subunit gamma 2 novel protein |
chr9_-_107489754 | 8.95 |
ENST00000610832.1
ENST00000374672.5 |
KLF4
|
Kruppel like factor 4 |
chr4_-_57110373 | 8.89 |
ENST00000295666.6
ENST00000514062.2 |
IGFBP7
|
insulin like growth factor binding protein 7 |
chr4_-_56681288 | 8.85 |
ENST00000556376.6
ENST00000420433.6 |
HOPX
|
HOP homeobox |
chr19_-_19192122 | 8.78 |
ENST00000444486.7
ENST00000514819.7 ENST00000585679.1 ENST00000462790.8 |
MEF2B
BORCS8-MEF2B
BORCS8
|
myocyte enhancer factor 2B BORCS8-MEF2B readthrough BLOC-1 related complex subunit 8 |
chr7_-_40134610 | 8.73 |
ENST00000306984.8
|
MPLKIP
|
M-phase specific PLK1 interacting protein |
chr1_+_171314171 | 8.56 |
ENST00000367749.4
|
FMO4
|
flavin containing dimethylaniline monoxygenase 4 |
chr10_+_94683722 | 8.53 |
ENST00000285979.11
|
CYP2C18
|
cytochrome P450 family 2 subfamily C member 18 |
chr22_+_22327298 | 8.47 |
ENST00000390291.2
|
IGLV1-50
|
immunoglobulin lambda variable 1-50 (non-functional) |
chr10_-_97445850 | 8.29 |
ENST00000477692.6
ENST00000485122.6 ENST00000370886.9 ENST00000370885.8 ENST00000370902.8 ENST00000370884.5 |
EXOSC1
|
exosome component 1 |
chr5_+_150497772 | 8.20 |
ENST00000523767.5
|
NDST1
|
N-deacetylase and N-sulfotransferase 1 |
chr4_-_56681588 | 8.13 |
ENST00000554144.5
ENST00000381260.7 |
HOPX
|
HOP homeobox |
chr4_+_95051671 | 8.10 |
ENST00000440890.7
|
BMPR1B
|
bone morphogenetic protein receptor type 1B |
chr19_-_51027662 | 8.03 |
ENST00000594768.5
|
KLK11
|
kallikrein related peptidase 11 |
chr5_-_74767105 | 8.02 |
ENST00000509430.5
ENST00000296805.8 ENST00000345239.6 ENST00000427854.6 ENST00000506778.1 |
GFM2
|
GTP dependent ribosome recycling factor mitochondrial 2 |
chr3_+_150546765 | 7.96 |
ENST00000406576.7
ENST00000460851.6 ENST00000482093.5 ENST00000273435.9 |
EIF2A
|
eukaryotic translation initiation factor 2A |
chr17_-_65056659 | 7.88 |
ENST00000439174.7
|
GNA13
|
G protein subunit alpha 13 |
chr2_+_88885397 | 7.75 |
ENST00000390243.2
|
IGKV4-1
|
immunoglobulin kappa variable 4-1 |
chr10_+_119207560 | 7.61 |
ENST00000392870.3
|
GRK5
|
G protein-coupled receptor kinase 5 |
chr1_-_1361777 | 7.61 |
ENST00000477278.3
|
MXRA8
|
matrix remodeling associated 8 |
chr7_-_100428657 | 7.55 |
ENST00000360951.8
ENST00000398027.6 ENST00000684423.1 ENST00000472716.1 |
ZCWPW1
|
zinc finger CW-type and PWWP domain containing 1 |
chr1_+_206770764 | 7.53 |
ENST00000656872.2
ENST00000659997.2 |
IL19
|
interleukin 19 |
chr12_-_11269696 | 7.51 |
ENST00000381842.7
|
PRB3
|
proline rich protein BstNI subfamily 3 |
chr1_+_32539418 | 7.49 |
ENST00000373510.9
ENST00000316459.4 |
ZBTB8A
|
zinc finger and BTB domain containing 8A |
chr3_+_38282294 | 7.47 |
ENST00000466887.5
ENST00000448498.6 |
SLC22A14
|
solute carrier family 22 member 14 |
chr14_-_77320813 | 7.46 |
ENST00000682467.1
|
POMT2
|
protein O-mannosyltransferase 2 |
chr11_-_116837586 | 7.44 |
ENST00000375320.5
ENST00000359492.6 ENST00000375329.6 ENST00000375323.5 ENST00000236850.5 |
APOA1
|
apolipoprotein A1 |
chr9_-_33447553 | 7.27 |
ENST00000645858.1
ENST00000297991.6 |
AQP3
|
aquaporin 3 (Gill blood group) |
chr7_+_142800957 | 7.20 |
ENST00000466254.1
|
TRBC2
|
T cell receptor beta constant 2 |
chr22_+_41800662 | 7.19 |
ENST00000402061.7
ENST00000255784.6 |
CCDC134
|
coiled-coil domain containing 134 |
chr6_-_109009498 | 7.05 |
ENST00000356644.7
|
SESN1
|
sestrin 1 |
chr21_-_42879516 | 6.99 |
ENST00000330317.6
ENST00000398208.3 |
WDR4
|
WD repeat domain 4 |
chr17_-_18314956 | 6.96 |
ENST00000321105.10
ENST00000542570.5 |
TOP3A
|
DNA topoisomerase III alpha |
chr1_-_161309961 | 6.91 |
ENST00000533357.5
ENST00000672602.2 ENST00000526189.3 |
MPZ
|
myelin protein zero |
chr12_+_10213417 | 6.88 |
ENST00000546017.5
ENST00000535576.5 ENST00000539170.5 |
GABARAPL1
|
GABA type A receptor associated protein like 1 |
chr12_-_11269805 | 6.82 |
ENST00000538488.2
|
PRB3
|
proline rich protein BstNI subfamily 3 |
chr11_-_5269933 | 6.81 |
ENST00000396895.3
|
HBE1
|
hemoglobin subunit epsilon 1 |
chr22_-_35617321 | 6.80 |
ENST00000397326.7
ENST00000442617.1 |
MB
|
myoglobin |
chr22_+_22811737 | 6.79 |
ENST00000390315.3
|
IGLV3-10
|
immunoglobulin lambda variable 3-10 |
chr7_+_100219236 | 6.75 |
ENST00000317271.2
|
PVRIG
|
PVR related immunoglobulin domain containing |
chr14_-_77320741 | 6.64 |
ENST00000682795.1
ENST00000682247.1 |
POMT2
|
protein O-mannosyltransferase 2 |
chr7_+_40134966 | 6.62 |
ENST00000401647.7
ENST00000628514.3 ENST00000335693.9 ENST00000416370.2 |
SUGCT
|
succinyl-CoA:glutarate-CoA transferase |
chr2_-_219308963 | 6.61 |
ENST00000423636.6
ENST00000442029.5 ENST00000412847.5 |
PTPRN
|
protein tyrosine phosphatase receptor type N |
chr19_+_16324817 | 6.38 |
ENST00000248071.6
ENST00000592003.1 |
KLF2
|
Kruppel like factor 2 |
chr1_-_56966133 | 6.37 |
ENST00000535057.5
ENST00000543257.5 |
C8B
|
complement C8 beta chain |
chr1_-_16018005 | 6.36 |
ENST00000406363.2
ENST00000411503.5 ENST00000311890.14 ENST00000487046.1 |
HSPB7
|
heat shock protein family B (small) member 7 |
chr14_-_106235582 | 6.35 |
ENST00000390607.2
|
IGHV3-21
|
immunoglobulin heavy variable 3-21 |
chr2_-_210315160 | 6.33 |
ENST00000352451.4
|
MYL1
|
myosin light chain 1 |
chr19_-_38869921 | 6.32 |
ENST00000593809.1
ENST00000593424.5 |
RINL
|
Ras and Rab interactor like |
chr9_+_129665603 | 6.31 |
ENST00000372469.6
|
PRRX2
|
paired related homeobox 2 |
chr16_-_70678315 | 6.27 |
ENST00000562883.6
|
MTSS2
|
MTSS I-BAR domain containing 2 |
chr11_-_10568571 | 6.25 |
ENST00000529598.1
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1 |
chr9_-_114078293 | 6.18 |
ENST00000265132.8
|
AMBP
|
alpha-1-microglobulin/bikunin precursor |
chr19_-_3600581 | 6.18 |
ENST00000589966.1
|
TBXA2R
|
thromboxane A2 receptor |
chr2_-_88979016 | 6.18 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
chrX_+_85244075 | 6.15 |
ENST00000276123.7
|
ZNF711
|
zinc finger protein 711 |
chr2_+_89862438 | 6.15 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
chr1_-_201399525 | 6.13 |
ENST00000367313.4
|
LAD1
|
ladinin 1 |
chr14_-_105940235 | 6.12 |
ENST00000390593.2
|
IGHV6-1
|
immunoglobulin heavy variable 6-1 |
chr11_-_10568650 | 6.09 |
ENST00000256178.8
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1 |
chr17_+_18315273 | 6.05 |
ENST00000406438.5
|
SMCR8
|
SMCR8-C9orf72 complex subunit |
chrX_+_35798791 | 6.04 |
ENST00000399985.1
|
MAGEB16
|
MAGE family member B16 |
chr17_+_42900791 | 6.03 |
ENST00000592383.5
ENST00000253801.7 ENST00000585489.1 |
G6PC1
|
glucose-6-phosphatase catalytic subunit 1 |
chr7_+_44104326 | 5.99 |
ENST00000223357.8
|
AEBP1
|
AE binding protein 1 |
chr12_+_21526287 | 5.98 |
ENST00000256969.7
|
SPX
|
spexin hormone |
chr1_+_158355894 | 5.98 |
ENST00000368162.2
|
CD1E
|
CD1e molecule |
chrY_-_2787676 | 5.95 |
ENST00000383070.2
|
SRY
|
sex determining region Y |
chr11_+_83156988 | 5.88 |
ENST00000298281.8
ENST00000530660.5 |
PCF11
|
PCF11 cleavage and polyadenylation factor subunit |
chr15_+_33968484 | 5.86 |
ENST00000383263.7
|
CHRM5
|
cholinergic receptor muscarinic 5 |
chr7_+_142791635 | 5.85 |
ENST00000633705.1
|
TRBC1
|
T cell receptor beta constant 1 |
chr14_-_21024092 | 5.84 |
ENST00000554398.5
|
NDRG2
|
NDRG family member 2 |
chr12_+_32106762 | 5.80 |
ENST00000551848.1
ENST00000652176.1 |
BICD1
|
BICD cargo adaptor 1 |
chr3_-_50303565 | 5.74 |
ENST00000266031.8
ENST00000395143.6 ENST00000457214.6 ENST00000447605.2 ENST00000395144.7 ENST00000418723.1 |
HYAL1
|
hyaluronidase 1 |
chr6_+_32637419 | 5.71 |
ENST00000374949.2
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1 |
chrX_-_155334580 | 5.71 |
ENST00000369449.7
ENST00000321926.4 |
CLIC2
|
chloride intracellular channel 2 |
chr22_+_22357739 | 5.67 |
ENST00000390294.2
|
IGLV1-47
|
immunoglobulin lambda variable 1-47 |
chr11_-_57237183 | 5.66 |
ENST00000606794.1
|
APLNR
|
apelin receptor |
chr2_-_36966471 | 5.66 |
ENST00000379213.3
|
STRN
|
striatin |
chr22_+_22380766 | 5.65 |
ENST00000390297.3
|
IGLV1-44
|
immunoglobulin lambda variable 1-44 |
chrX_+_85244032 | 5.55 |
ENST00000373165.7
|
ZNF711
|
zinc finger protein 711 |
chr11_-_207221 | 5.55 |
ENST00000486280.1
ENST00000332865.10 ENST00000529614.6 ENST00000325147.13 ENST00000410108.5 ENST00000382762.7 |
BET1L
|
Bet1 golgi vesicular membrane trafficking protein like |
chr1_-_151146643 | 5.52 |
ENST00000613223.1
|
SEMA6C
|
semaphorin 6C |
chr16_+_2752622 | 5.44 |
ENST00000576924.5
ENST00000575009.5 ENST00000301740.13 ENST00000630499.2 ENST00000576415.5 ENST00000571378.5 |
SRRM2
|
serine/arginine repetitive matrix 2 |
chr2_-_89085787 | 5.43 |
ENST00000390252.2
|
IGKV3-15
|
immunoglobulin kappa variable 3-15 |
chr2_+_113127588 | 5.42 |
ENST00000409930.4
|
IL1RN
|
interleukin 1 receptor antagonist |
chr1_+_161524539 | 5.41 |
ENST00000309758.6
|
HSPA6
|
heat shock protein family A (Hsp70) member 6 |
chr5_+_67004618 | 5.40 |
ENST00000261569.11
ENST00000436277.5 |
MAST4
|
microtubule associated serine/threonine kinase family member 4 |
chr2_+_110732584 | 5.39 |
ENST00000340561.8
|
ACOXL
|
acyl-CoA oxidase like |
chr3_+_129528632 | 5.27 |
ENST00000296271.4
|
RHO
|
rhodopsin |
chr17_-_78782257 | 5.25 |
ENST00000591455.5
ENST00000446868.7 ENST00000361101.8 ENST00000589296.5 |
CYTH1
|
cytohesin 1 |
chr12_-_102480638 | 5.21 |
ENST00000392904.5
|
IGF1
|
insulin like growth factor 1 |
chr12_-_102480552 | 5.20 |
ENST00000337514.11
ENST00000307046.8 |
IGF1
|
insulin like growth factor 1 |
chr12_-_16606795 | 5.19 |
ENST00000447609.5
|
LMO3
|
LIM domain only 3 |
chr6_+_31615984 | 5.18 |
ENST00000376049.4
|
AIF1
|
allograft inflammatory factor 1 |
chrX_+_18425597 | 5.17 |
ENST00000623535.2
ENST00000674046.1 |
CDKL5
|
cyclin dependent kinase like 5 |
chr9_+_136945234 | 5.17 |
ENST00000371634.7
|
C8G
|
complement C8 gamma chain |
chr4_+_165378998 | 5.16 |
ENST00000402744.9
|
CPE
|
carboxypeptidase E |
chr9_+_137139481 | 5.13 |
ENST00000371546.8
ENST00000371550.8 ENST00000371553.7 ENST00000371555.8 ENST00000371559.8 ENST00000371560.4 |
GRIN1
|
glutamate ionotropic receptor NMDA type subunit 1 |
chr22_+_22431949 | 5.13 |
ENST00000390301.3
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
chr14_-_21023954 | 5.09 |
ENST00000554094.5
|
NDRG2
|
NDRG family member 2 |
chr20_-_17531366 | 5.08 |
ENST00000377873.8
|
BFSP1
|
beaded filament structural protein 1 |
chr19_-_51024211 | 5.03 |
ENST00000593681.5
|
KLK11
|
kallikrein related peptidase 11 |
chr1_+_36224410 | 5.02 |
ENST00000469141.6
ENST00000648638.1 ENST00000354618.10 |
THRAP3
|
thyroid hormone receptor associated protein 3 |
chr2_+_127423265 | 4.99 |
ENST00000402125.2
|
PROC
|
protein C, inactivator of coagulation factors Va and VIIIa |
chr1_+_236686454 | 4.99 |
ENST00000542672.6
ENST00000366578.6 ENST00000682015.1 ENST00000651275.1 |
ACTN2
|
actinin alpha 2 |
chr11_+_28108248 | 4.99 |
ENST00000406787.7
ENST00000403099.5 ENST00000407364.8 |
METTL15
|
methyltransferase like 15 |
chr22_+_26621952 | 4.96 |
ENST00000354760.4
|
CRYBA4
|
crystallin beta A4 |
chr12_+_119667859 | 4.95 |
ENST00000541640.5
|
PRKAB1
|
protein kinase AMP-activated non-catalytic subunit beta 1 |
chr1_-_151146611 | 4.94 |
ENST00000341697.7
ENST00000368914.8 |
SEMA6C
|
semaphorin 6C |
chr22_-_23751080 | 4.90 |
ENST00000341976.5
|
ZNF70
|
zinc finger protein 70 |
chr2_+_70900546 | 4.89 |
ENST00000234392.3
|
VAX2
|
ventral anterior homeobox 2 |
chr14_+_77320996 | 4.87 |
ENST00000361389.8
ENST00000554279.5 ENST00000557639.5 ENST00000349555.7 ENST00000216465.10 ENST00000556627.5 ENST00000557053.5 |
GSTZ1
|
glutathione S-transferase zeta 1 |
chr19_+_48364361 | 4.85 |
ENST00000344846.7
|
SYNGR4
|
synaptogyrin 4 |
chr1_-_25430147 | 4.85 |
ENST00000349320.7
|
RHCE
|
Rh blood group CcEe antigens |
chr7_-_158829519 | 4.84 |
ENST00000251527.10
ENST00000652148.1 |
ESYT2
|
extended synaptotagmin 2 |
chr18_-_55302613 | 4.83 |
ENST00000561831.7
|
TCF4
|
transcription factor 4 |
chr16_+_28878480 | 4.83 |
ENST00000395503.9
|
ATP2A1
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 |
chr6_+_31927486 | 4.79 |
ENST00000442278.6
|
C2
|
complement C2 |
chr9_+_137665916 | 4.79 |
ENST00000636027.1
|
EHMT1
|
euchromatic histone lysine methyltransferase 1 |
chr19_-_6110463 | 4.75 |
ENST00000587181.1
ENST00000587321.1 ENST00000586806.1 ENST00000303657.10 ENST00000589742.5 ENST00000592546.5 |
RFX2
|
regulatory factor X2 |
chr11_+_2302119 | 4.75 |
ENST00000381121.7
|
TSPAN32
|
tetraspanin 32 |
chr3_-_132722365 | 4.72 |
ENST00000337331.10
ENST00000383282.3 ENST00000683570.1 |
NPHP3
|
nephrocystin 3 |
chr1_+_212285383 | 4.65 |
ENST00000261461.7
|
PPP2R5A
|
protein phosphatase 2 regulatory subunit B'alpha |
chrX_+_11293411 | 4.64 |
ENST00000348912.4
ENST00000380714.7 ENST00000380712.7 |
AMELX
|
amelogenin X-linked |
chr17_-_41612757 | 4.64 |
ENST00000301653.9
ENST00000593067.1 |
KRT16
|
keratin 16 |
chr19_-_17377334 | 4.63 |
ENST00000252590.9
ENST00000599426.1 |
PLVAP
|
plasmalemma vesicle associated protein |
chrX_+_85243983 | 4.62 |
ENST00000674551.1
|
ZNF711
|
zinc finger protein 711 |
chr17_+_42851167 | 4.60 |
ENST00000613571.1
ENST00000308423.7 |
AOC3
|
amine oxidase copper containing 3 |
chr12_-_4379712 | 4.60 |
ENST00000237837.2
|
FGF23
|
fibroblast growth factor 23 |
chr3_+_178536407 | 4.60 |
ENST00000452583.6
|
KCNMB2
|
potassium calcium-activated channel subfamily M regulatory beta subunit 2 |
chr7_+_116672357 | 4.58 |
ENST00000456159.1
|
MET
|
MET proto-oncogene, receptor tyrosine kinase |
chr12_-_52520371 | 4.54 |
ENST00000549420.1
ENST00000252242.9 ENST00000551275.1 ENST00000546577.1 |
KRT5
|
keratin 5 |
chr8_-_86743626 | 4.50 |
ENST00000320005.6
|
CNGB3
|
cyclic nucleotide gated channel subunit beta 3 |
chr18_-_55586092 | 4.47 |
ENST00000563888.6
ENST00000540999.5 ENST00000627685.2 |
TCF4
|
transcription factor 4 |
chrX_+_18425579 | 4.43 |
ENST00000379996.7
|
CDKL5
|
cyclin dependent kinase like 5 |
chr2_+_188291911 | 4.42 |
ENST00000410051.5
|
GULP1
|
GULP PTB domain containing engulfment adaptor 1 |
chr14_+_100376398 | 4.40 |
ENST00000554998.5
ENST00000402312.8 ENST00000335290.10 ENST00000554175.5 |
WDR25
|
WD repeat domain 25 |
chr6_-_160258814 | 4.38 |
ENST00000366953.8
|
SLC22A2
|
solute carrier family 22 member 2 |
chr7_-_35695120 | 4.38 |
ENST00000311350.8
ENST00000396081.5 |
HERPUD2
|
HERPUD family member 2 |
chr3_+_184186023 | 4.38 |
ENST00000429586.6
ENST00000292808.5 |
ABCF3
|
ATP binding cassette subfamily F member 3 |
chr3_+_186613052 | 4.36 |
ENST00000411641.7
ENST00000273784.5 |
AHSG
|
alpha 2-HS glycoprotein |
chr7_-_17940468 | 4.35 |
ENST00000611725.4
ENST00000409604.1 ENST00000428135.7 |
SNX13
|
sorting nexin 13 |
chr16_-_57971086 | 4.34 |
ENST00000564448.5
ENST00000311183.8 |
CNGB1
|
cyclic nucleotide gated channel subunit beta 1 |
chr19_-_44500503 | 4.33 |
ENST00000587047.1
ENST00000391956.8 ENST00000221327.8 ENST00000592529.6 ENST00000591064.1 |
ZNF180
|
zinc finger protein 180 |
chr1_-_206946448 | 4.30 |
ENST00000356495.5
|
PIGR
|
polymeric immunoglobulin receptor |
chr12_-_57826295 | 4.30 |
ENST00000549039.5
|
CTDSP2
|
CTD small phosphatase 2 |
chrX_-_54994022 | 4.29 |
ENST00000614686.1
ENST00000374992.6 ENST00000375006.8 |
PFKFB1
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 |
chr17_-_9905248 | 4.29 |
ENST00000226193.6
|
RCVRN
|
recoverin |
chr6_-_33009568 | 4.28 |
ENST00000374813.1
ENST00000229829.7 |
HLA-DOA
|
major histocompatibility complex, class II, DO alpha |
chr9_-_94593810 | 4.25 |
ENST00000375337.4
|
FBP2
|
fructose-bisphosphatase 2 |
chr6_+_31927683 | 4.24 |
ENST00000456570.5
|
ENSG00000244255.5
|
novel complement component 2 (C2) and complement factor B (CFB) protein |
chr11_-_63015831 | 4.23 |
ENST00000430500.6
ENST00000336232.7 |
SLC22A8
|
solute carrier family 22 member 8 |
chr17_-_3292600 | 4.23 |
ENST00000615105.1
|
OR3A1
|
olfactory receptor family 3 subfamily A member 1 |
chr9_+_27109200 | 4.23 |
ENST00000380036.10
|
TEK
|
TEK receptor tyrosine kinase |
chr2_+_90234809 | 4.22 |
ENST00000443397.5
|
IGKV3D-7
|
immunoglobulin kappa variable 3D-7 |
chr11_-_63015804 | 4.13 |
ENST00000535878.5
ENST00000545207.5 |
SLC22A8
|
solute carrier family 22 member 8 |
chr7_-_113919000 | 4.10 |
ENST00000284601.4
|
PPP1R3A
|
protein phosphatase 1 regulatory subunit 3A |
chr2_+_90220727 | 4.10 |
ENST00000471857.2
|
IGKV1D-8
|
immunoglobulin kappa variable 1D-8 |
chr10_+_124461800 | 4.09 |
ENST00000368842.10
ENST00000392757.8 ENST00000368839.1 |
LHPP
|
phospholysine phosphohistidine inorganic pyrophosphate phosphatase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.1 | 36.6 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
6.7 | 127.7 | GO:0015671 | oxygen transport(GO:0015671) |
6.2 | 24.9 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
5.7 | 28.3 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
5.2 | 15.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
4.5 | 13.6 | GO:0048769 | sarcomerogenesis(GO:0048769) |
3.9 | 11.6 | GO:1904582 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
3.4 | 23.7 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
3.2 | 22.7 | GO:0071279 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) cellular response to cobalt ion(GO:0071279) |
3.2 | 9.7 | GO:1904692 | positive regulation of type B pancreatic cell proliferation(GO:1904692) |
2.8 | 8.5 | GO:0043449 | olfactory learning(GO:0008355) cellular alkene metabolic process(GO:0043449) |
2.6 | 12.8 | GO:1904075 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
2.5 | 7.4 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
2.4 | 9.6 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) negative regulation of endothelial cell chemotaxis(GO:2001027) |
2.3 | 11.4 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
2.3 | 9.1 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
2.3 | 6.8 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
2.2 | 6.6 | GO:0036047 | protein demalonylation(GO:0036046) peptidyl-lysine demalonylation(GO:0036047) protein desuccinylation(GO:0036048) peptidyl-lysine desuccinylation(GO:0036049) protein deglutarylation(GO:0061698) peptidyl-lysine deglutarylation(GO:0061699) |
2.1 | 4.3 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
2.1 | 6.4 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
2.1 | 8.5 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
2.1 | 6.2 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
2.0 | 8.2 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
2.0 | 8.0 | GO:1990928 | response to amino acid starvation(GO:1990928) |
2.0 | 15.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
2.0 | 5.9 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
2.0 | 5.9 | GO:0001554 | luteolysis(GO:0001554) |
1.9 | 3.8 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
1.8 | 10.5 | GO:0008218 | bioluminescence(GO:0008218) |
1.7 | 5.0 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
1.5 | 7.3 | GO:0070295 | renal water absorption(GO:0070295) |
1.4 | 5.7 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
1.4 | 4.3 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
1.4 | 5.4 | GO:0046968 | peptide antigen transport(GO:0046968) |
1.4 | 4.1 | GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
1.3 | 10.8 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
1.3 | 4.0 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
1.3 | 6.5 | GO:0009624 | response to nematode(GO:0009624) |
1.3 | 2.6 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
1.3 | 94.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
1.2 | 5.0 | GO:0086097 | microspike assembly(GO:0030035) phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
1.2 | 9.6 | GO:2000467 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) positive regulation of glycogen (starch) synthase activity(GO:2000467) |
1.2 | 4.7 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.2 | 24.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
1.2 | 5.9 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
1.2 | 2.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
1.2 | 8.1 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) negative regulation of chondrocyte proliferation(GO:1902731) |
1.2 | 4.6 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
1.2 | 4.6 | GO:1904383 | response to sodium phosphate(GO:1904383) |
1.1 | 8.9 | GO:0051414 | response to cortisol(GO:0051414) |
1.1 | 4.4 | GO:0002331 | pre-B cell differentiation(GO:0002329) pre-B cell allelic exclusion(GO:0002331) |
1.1 | 5.4 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
1.1 | 4.2 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
1.0 | 5.2 | GO:0030070 | insulin processing(GO:0030070) |
1.0 | 8.2 | GO:0015014 | protein sulfation(GO:0006477) heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.0 | 6.0 | GO:1904306 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) |
1.0 | 3.9 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
1.0 | 2.9 | GO:0015847 | putrescine transport(GO:0015847) positive regulation of polyamine transmembrane transport(GO:1902269) |
1.0 | 2.9 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.9 | 8.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.9 | 6.5 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) positive regulation of autophagosome maturation(GO:1901098) |
0.9 | 11.0 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.9 | 1.8 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.9 | 15.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.9 | 2.7 | GO:0003097 | renal water transport(GO:0003097) |
0.9 | 1.8 | GO:0001757 | somite specification(GO:0001757) |
0.9 | 8.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.9 | 3.5 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.9 | 16.8 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.9 | 7.1 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.9 | 3.5 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.9 | 2.6 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.9 | 13.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.8 | 2.5 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.8 | 7.6 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.8 | 2.5 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.8 | 3.3 | GO:0002290 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
0.8 | 2.5 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.8 | 4.0 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.8 | 2.4 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.8 | 2.4 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.8 | 2.4 | GO:1901874 | negative regulation of post-translational protein modification(GO:1901874) |
0.8 | 8.6 | GO:0042737 | drug catabolic process(GO:0042737) |
0.8 | 3.9 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.8 | 5.4 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.8 | 4.6 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.8 | 1.5 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.8 | 4.6 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.8 | 4.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.7 | 3.0 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.7 | 2.2 | GO:0070844 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.7 | 2.9 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.7 | 4.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.7 | 2.9 | GO:0010193 | response to ozone(GO:0010193) |
0.7 | 2.1 | GO:1903281 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.7 | 4.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) floor plate development(GO:0033504) |
0.7 | 3.5 | GO:0045959 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
0.7 | 2.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.7 | 50.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.7 | 4.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.7 | 1.3 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.7 | 17.1 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.7 | 2.6 | GO:0050957 | equilibrioception(GO:0050957) |
0.7 | 2.0 | GO:0071529 | cementum mineralization(GO:0071529) |
0.6 | 9.7 | GO:0035878 | nail development(GO:0035878) |
0.6 | 10.9 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.6 | 1.9 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.6 | 18.5 | GO:0015695 | organic cation transport(GO:0015695) |
0.6 | 7.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.6 | 1.9 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.6 | 2.5 | GO:0019724 | B cell mediated immunity(GO:0019724) |
0.6 | 3.7 | GO:0018343 | protein farnesylation(GO:0018343) |
0.6 | 3.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.6 | 17.0 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.6 | 9.1 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.6 | 3.6 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.6 | 12.3 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.6 | 3.5 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.6 | 15.4 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.6 | 2.2 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
0.6 | 2.8 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.6 | 2.8 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.6 | 5.0 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.5 | 2.7 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.5 | 6.0 | GO:0048003 | antigen processing and presentation via MHC class Ib(GO:0002475) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.5 | 7.5 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.5 | 7.0 | GO:0006265 | DNA topological change(GO:0006265) |
0.5 | 1.6 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.5 | 10.0 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.5 | 2.1 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.5 | 15.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.5 | 5.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.5 | 2.0 | GO:0060023 | soft palate development(GO:0060023) |
0.5 | 2.0 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) positive regulation of blood vessel remodeling(GO:2000504) |
0.5 | 3.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.5 | 6.0 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.5 | 3.9 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.5 | 11.0 | GO:0007398 | ectoderm development(GO:0007398) |
0.5 | 2.8 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.5 | 5.2 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.5 | 0.9 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.4 | 3.5 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.4 | 5.2 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.4 | 4.8 | GO:0001675 | acrosome assembly(GO:0001675) |
0.4 | 1.3 | GO:1903027 | regulation of opsonization(GO:1903027) |
0.4 | 4.3 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.4 | 30.2 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.4 | 4.6 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.4 | 2.5 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.4 | 2.4 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
0.4 | 13.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.4 | 3.5 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.4 | 7.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.4 | 2.3 | GO:0002005 | angiotensin catabolic process in blood(GO:0002005) |
0.4 | 3.7 | GO:0008272 | sulfate transport(GO:0008272) |
0.4 | 4.8 | GO:0060992 | response to fungicide(GO:0060992) |
0.4 | 1.8 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.4 | 2.1 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
0.4 | 7.8 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.4 | 6.0 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.4 | 2.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.3 | 5.1 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.3 | 2.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 4.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 1.3 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.3 | 4.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.3 | 1.6 | GO:1902612 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
0.3 | 11.4 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.3 | 14.3 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.3 | 1.2 | GO:0002880 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.3 | 0.6 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
0.3 | 6.9 | GO:0098743 | cell aggregation(GO:0098743) |
0.3 | 3.0 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.3 | 1.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.3 | 3.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.3 | 4.2 | GO:0034505 | tooth mineralization(GO:0034505) |
0.3 | 3.1 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.3 | 2.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.3 | 1.1 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.3 | 1.9 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.3 | 3.0 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.3 | 5.7 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 1.1 | GO:0035962 | response to interleukin-13(GO:0035962) |
0.3 | 0.8 | GO:0060005 | vestibular reflex(GO:0060005) |
0.3 | 2.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.3 | 6.4 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.3 | 1.8 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.3 | 3.5 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.2 | 3.7 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.2 | 1.0 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 0.7 | GO:0016999 | antibiotic metabolic process(GO:0016999) cellular amide catabolic process(GO:0043605) |
0.2 | 0.7 | GO:0001810 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) positive regulation of hypersensitivity(GO:0002885) type I hypersensitivity(GO:0016068) |
0.2 | 1.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 8.3 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.2 | 2.7 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.2 | 3.7 | GO:0097320 | membrane tubulation(GO:0097320) |
0.2 | 5.0 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 5.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 2.0 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.2 | 1.6 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.2 | 3.0 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 1.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 1.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 3.9 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 4.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.2 | 3.5 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 0.8 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.2 | 0.8 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.2 | 1.6 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.2 | 3.9 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.2 | 0.6 | GO:1990451 | cellular stress response to acidic pH(GO:1990451) |
0.2 | 3.3 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.2 | 4.0 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.2 | 0.9 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.2 | 2.2 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 2.9 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.2 | 6.0 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.2 | 1.3 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.4 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.2 | 18.2 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.2 | 4.0 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 2.4 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.2 | 2.6 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.2 | 1.5 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.2 | 0.8 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 1.7 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 1.7 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 0.5 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.2 | 1.6 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.2 | 5.9 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.2 | 1.0 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.2 | 2.8 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.2 | 1.1 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.2 | 2.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 1.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 1.1 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.2 | 3.2 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.1 | 3.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 3.9 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 2.6 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.4 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.1 | 2.7 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 1.8 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.6 | GO:0061528 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) uterine smooth muscle contraction(GO:0070471) regulation of uterine smooth muscle contraction(GO:0070472) positive regulation of uterine smooth muscle contraction(GO:0070474) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
0.1 | 1.4 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.1 | 0.7 | GO:0005997 | xylulose metabolic process(GO:0005997) pentose catabolic process(GO:0019323) |
0.1 | 3.8 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 1.5 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.1 | 2.7 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 5.3 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.1 | 0.5 | GO:0035799 | optic nerve formation(GO:0021634) vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve formation(GO:0021650) regulation of metanephros size(GO:0035566) ureter maturation(GO:0035799) optic chiasma development(GO:0061360) regulation of optic nerve formation(GO:2000595) positive regulation of optic nerve formation(GO:2000597) |
0.1 | 1.0 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.1 | 0.8 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 3.1 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.1 | 3.4 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 0.6 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.7 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.3 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.1 | 2.1 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.1 | 15.0 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.1 | 0.3 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 2.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.2 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 1.9 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 2.2 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.1 | 2.5 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 2.0 | GO:0044062 | regulation of excretion(GO:0044062) |
0.1 | 1.3 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.1 | 0.6 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.1 | 1.6 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 2.7 | GO:0032402 | melanosome transport(GO:0032402) |
0.1 | 1.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.5 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 1.7 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 4.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 2.1 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.1 | 2.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 1.3 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 3.2 | GO:1900274 | regulation of phospholipase C activity(GO:1900274) |
0.1 | 1.4 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 1.9 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 11.3 | GO:0007586 | digestion(GO:0007586) |
0.1 | 0.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 1.5 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.1 | 1.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 2.7 | GO:0030818 | negative regulation of cAMP biosynthetic process(GO:0030818) |
0.1 | 2.6 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 5.8 | GO:0030239 | myofibril assembly(GO:0030239) |
0.1 | 0.8 | GO:0071467 | cellular response to pH(GO:0071467) |
0.1 | 4.0 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.1 | 2.0 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.3 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.1 | 4.0 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.1 | 1.0 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.9 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 1.8 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.1 | 3.9 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.7 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.1 | 0.8 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.3 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.1 | 0.2 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 0.3 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 2.3 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 4.8 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 1.1 | GO:0006833 | water transport(GO:0006833) |
0.1 | 4.4 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.5 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) regulation of endocannabinoid signaling pathway(GO:2000124) |
0.1 | 0.2 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) regulation of TORC2 signaling(GO:1903939) negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.1 | 2.3 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.1 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.0 | 1.9 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.5 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.0 | 0.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.9 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.6 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 1.8 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 1.1 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 1.2 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.4 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
0.0 | 4.0 | GO:0071222 | cellular response to lipopolysaccharide(GO:0071222) |
0.0 | 0.2 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.0 | 1.5 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 2.1 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.0 | 2.2 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
0.0 | 4.3 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.6 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.5 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.0 | 0.1 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
0.0 | 3.2 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.0 | 1.4 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.0 | 0.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.6 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 4.7 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 0.6 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.8 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 1.3 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 1.9 | GO:0055001 | muscle cell development(GO:0055001) |
0.0 | 1.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.2 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 2.9 | GO:0007254 | JNK cascade(GO:0007254) |
0.0 | 0.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.3 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.0 | 0.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.8 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.0 | 0.7 | GO:0005977 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
17.8 | 71.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
4.4 | 30.9 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
4.2 | 54.9 | GO:0005833 | hemoglobin complex(GO:0005833) |
2.9 | 23.5 | GO:0005579 | membrane attack complex(GO:0005579) |
2.5 | 7.5 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
2.3 | 44.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
2.1 | 22.7 | GO:0043203 | axon hillock(GO:0043203) |
2.0 | 36.6 | GO:0042627 | chylomicron(GO:0042627) |
2.0 | 8.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
1.7 | 91.3 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
1.3 | 4.0 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.3 | 12.8 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
1.2 | 11.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.2 | 3.5 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
1.0 | 6.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
1.0 | 5.9 | GO:0045298 | tubulin complex(GO:0045298) |
0.9 | 3.7 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.9 | 7.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.8 | 11.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.8 | 5.9 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.8 | 5.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.8 | 34.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.8 | 11.6 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
0.7 | 3.7 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.7 | 2.2 | GO:0070701 | mucus layer(GO:0070701) |
0.7 | 11.0 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.7 | 3.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.7 | 2.7 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.7 | 2.0 | GO:0005592 | collagen type XI trimer(GO:0005592) |
0.7 | 2.6 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.6 | 9.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.6 | 1.9 | GO:0030689 | Noc complex(GO:0030689) |
0.6 | 15.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.6 | 16.7 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.6 | 9.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.5 | 13.8 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.5 | 1.6 | GO:0098831 | cytoskeleton of presynaptic active zone(GO:0048788) presynaptic active zone cytoplasmic component(GO:0098831) presynaptic cytoskeleton(GO:0099569) |
0.5 | 2.5 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.5 | 1.9 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.5 | 1.4 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.4 | 0.9 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.4 | 5.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.4 | 3.6 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.4 | 8.9 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.4 | 2.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.3 | 2.4 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.3 | 2.7 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.3 | 13.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 4.8 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.3 | 2.2 | GO:1990745 | EARP complex(GO:1990745) |
0.3 | 5.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 9.1 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.3 | 2.5 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.3 | 6.5 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 13.4 | GO:0008305 | integrin complex(GO:0008305) |
0.3 | 2.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 2.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.3 | 1.9 | GO:0060091 | kinocilium(GO:0060091) |
0.3 | 1.4 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.3 | 0.8 | GO:0032426 | stereocilium tip(GO:0032426) |
0.3 | 41.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 3.2 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.3 | 8.9 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.3 | 5.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 12.0 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 2.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 4.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 2.8 | GO:0030897 | HOPS complex(GO:0030897) |
0.2 | 4.9 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.2 | 16.8 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 0.8 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 1.3 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.2 | 2.8 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 1.2 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.2 | 2.0 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 6.4 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 12.7 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 1.3 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 8.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 2.3 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.4 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.1 | 0.6 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.1 | 1.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 8.9 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 1.5 | GO:0016013 | syntrophin complex(GO:0016013) |
0.1 | 1.8 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 1.5 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 1.1 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.1 | 2.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 13.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 13.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 8.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 1.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.3 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 6.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 20.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 2.1 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) ATPase dependent transmembrane transport complex(GO:0098533) |
0.1 | 2.8 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 6.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 145.5 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 1.7 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 14.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 5.0 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 5.4 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.3 | GO:0032301 | MutSalpha complex(GO:0032301) |
0.1 | 8.7 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.1 | 7.5 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.1 | 14.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 2.0 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 2.4 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 7.0 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 3.3 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 6.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 2.3 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 2.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 12.2 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 5.6 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 4.5 | GO:0016605 | PML body(GO:0016605) |
0.0 | 2.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 1.7 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 1.4 | GO:0044216 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.7 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 3.9 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.9 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.9 | 132.8 | GO:0005344 | oxygen transporter activity(GO:0005344) |
6.2 | 30.9 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
6.1 | 36.6 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
3.4 | 23.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
3.0 | 8.9 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
2.3 | 7.0 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
2.2 | 6.6 | GO:0036054 | protein-malonyllysine demalonylase activity(GO:0036054) protein-succinyllysine desuccinylase activity(GO:0036055) protein-glutaryllysine deglutarylase activity(GO:0061697) |
2.1 | 10.6 | GO:0008410 | CoA-transferase activity(GO:0008410) |
2.1 | 6.2 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
2.0 | 8.2 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
2.0 | 11.9 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
2.0 | 5.9 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
2.0 | 27.4 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
1.9 | 5.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
1.9 | 9.6 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
1.9 | 13.3 | GO:0031433 | telethonin binding(GO:0031433) |
1.8 | 7.3 | GO:0015254 | glycerol channel activity(GO:0015254) |
1.8 | 8.9 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
1.7 | 10.1 | GO:0051373 | FATZ binding(GO:0051373) |
1.7 | 13.4 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
1.5 | 18.6 | GO:0008430 | selenium binding(GO:0008430) |
1.5 | 6.2 | GO:0019862 | IgA binding(GO:0019862) |
1.5 | 91.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
1.5 | 22.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.4 | 4.1 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
1.3 | 3.9 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
1.3 | 5.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
1.3 | 7.6 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
1.2 | 5.0 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
1.2 | 8.6 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.2 | 7.3 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
1.2 | 4.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.2 | 5.9 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
1.2 | 7.1 | GO:0070728 | leucine binding(GO:0070728) |
1.2 | 5.9 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
1.1 | 4.4 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) secondary active organic cation transmembrane transporter activity(GO:0008513) acetate ester transmembrane transporter activity(GO:1901375) |
1.1 | 4.2 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
1.0 | 3.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.0 | 5.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
1.0 | 3.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
1.0 | 2.9 | GO:0015489 | polyamine transmembrane transporter activity(GO:0015203) putrescine transmembrane transporter activity(GO:0015489) |
1.0 | 3.9 | GO:0052595 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.9 | 8.5 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.9 | 3.7 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.9 | 4.6 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.9 | 3.6 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.9 | 5.3 | GO:0070004 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
0.9 | 4.3 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.8 | 4.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.8 | 9.3 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.8 | 2.5 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.8 | 3.3 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
0.8 | 4.0 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.8 | 22.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.8 | 11.6 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.7 | 4.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.7 | 4.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.7 | 2.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.7 | 8.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.7 | 14.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.7 | 6.0 | GO:0030884 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
0.7 | 1.3 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.6 | 12.3 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.6 | 7.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.6 | 1.8 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.6 | 2.4 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.6 | 2.4 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.6 | 2.9 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.6 | 5.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.6 | 9.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.6 | 2.8 | GO:0004920 | type I interferon receptor activity(GO:0004905) interleukin-10 receptor activity(GO:0004920) |
0.5 | 2.7 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.5 | 4.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.5 | 4.9 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.5 | 4.8 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.5 | 23.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.5 | 1.9 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
0.5 | 2.4 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.5 | 2.4 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.5 | 2.4 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
0.5 | 13.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.5 | 4.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.5 | 3.7 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.5 | 62.9 | GO:0003823 | antigen binding(GO:0003823) |
0.4 | 2.2 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.4 | 1.3 | GO:0032090 | Pyrin domain binding(GO:0032090) |
0.4 | 1.8 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.4 | 9.1 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.4 | 3.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.4 | 1.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.4 | 16.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.4 | 3.4 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.4 | 7.9 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.4 | 2.0 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.4 | 1.6 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.4 | 5.2 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.4 | 41.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.4 | 5.2 | GO:0019841 | retinol binding(GO:0019841) |
0.4 | 2.0 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.4 | 15.5 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.4 | 2.7 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.4 | 3.5 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.4 | 1.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.4 | 2.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.4 | 2.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.4 | 1.8 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.4 | 2.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.3 | 3.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 3.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.3 | 4.4 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.3 | 4.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.3 | 15.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.3 | 0.9 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.3 | 1.8 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.3 | 1.5 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.3 | 2.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.3 | 7.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 9.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.3 | 2.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 1.2 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.3 | 0.6 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.3 | 1.5 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.3 | 2.0 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.3 | 5.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.3 | 5.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 6.4 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 7.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.3 | 1.1 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.3 | 4.7 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 5.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 2.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 11.0 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.2 | 6.1 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.2 | 4.8 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.2 | 1.0 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.2 | 6.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 5.9 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 1.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 8.0 | GO:0000049 | tRNA binding(GO:0000049) |
0.2 | 51.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 2.0 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.2 | 1.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 1.1 | GO:0001093 | TFIIB-class transcription factor binding(GO:0001093) |
0.2 | 11.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 1.1 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.2 | 2.1 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.2 | 2.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 3.7 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 1.6 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.2 | 1.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 2.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 4.6 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.2 | 5.9 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.2 | 1.9 | GO:0005549 | odorant binding(GO:0005549) |
0.2 | 3.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 0.6 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.2 | 2.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 0.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 16.2 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.2 | 2.5 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 0.3 | GO:0004040 | amidase activity(GO:0004040) |
0.2 | 3.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 5.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 5.3 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.2 | 4.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 12.0 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 2.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 3.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.6 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.1 | 2.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 2.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 4.6 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 2.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 3.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.8 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 2.6 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 1.1 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 2.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 2.4 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.5 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 6.1 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 3.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.4 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
0.1 | 3.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 7.1 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 9.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 1.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.7 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 1.8 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 1.5 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 11.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 4.5 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.3 | GO:0032143 | single thymine insertion binding(GO:0032143) |
0.1 | 2.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 2.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.8 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 1.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 2.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 1.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.5 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.9 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 3.8 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 9.8 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 2.7 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 1.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.8 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 3.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 3.6 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.4 | GO:0008865 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 1.0 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 1.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 1.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.6 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 1.3 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.4 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 2.8 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 1.1 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 1.2 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 3.0 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.6 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.6 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 9.3 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.2 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.0 | 2.6 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 2.2 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 1.2 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 5.4 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.0 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.3 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.2 | GO:0004383 | adenylate cyclase activity(GO:0004016) guanylate cyclase activity(GO:0004383) |
0.0 | 0.3 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.0 | 2.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.7 | GO:0019209 | kinase activator activity(GO:0019209) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 9.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.6 | 19.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.4 | 4.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.4 | 20.8 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.4 | 2.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 6.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 82.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 32.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.3 | 6.4 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.3 | 17.2 | PID BMP PATHWAY | BMP receptor signaling |
0.3 | 10.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 6.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 3.7 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 5.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 8.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 7.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 3.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 4.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 11.9 | PID SHP2 PATHWAY | SHP2 signaling |
0.2 | 4.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 5.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 1.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 7.4 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 6.0 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 5.8 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 7.0 | PID ATM PATHWAY | ATM pathway |
0.2 | 3.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 4.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 7.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 6.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 14.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 3.2 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 2.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 19.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 5.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 28.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 3.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 1.6 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 5.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 4.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 3.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 11.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 1.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 2.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 4.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 5.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 3.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 5.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 1.3 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 6.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 2.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 2.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 5.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 1.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 10.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 4.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 1.9 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 1.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 12.2 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 1.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 9.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.8 | 36.8 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
1.4 | 30.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.1 | 22.6 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
1.1 | 11.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.0 | 23.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.8 | 34.9 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.8 | 15.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.7 | 12.8 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.7 | 12.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.7 | 7.4 | REACTOME OPSINS | Genes involved in Opsins |
0.7 | 18.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.6 | 8.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.5 | 9.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.5 | 12.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 13.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.4 | 2.8 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.3 | 5.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.3 | 9.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.3 | 3.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 7.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.3 | 2.4 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.3 | 5.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 4.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.3 | 9.1 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.3 | 3.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.3 | 1.4 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.3 | 4.8 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.3 | 6.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 6.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 4.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 14.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 3.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 10.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 2.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 3.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 1.0 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 8.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 7.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 5.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 3.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 16.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.2 | 1.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 6.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 0.8 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 2.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 3.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 2.8 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 1.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 2.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 11.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 3.6 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 1.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 6.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 2.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 2.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 2.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 3.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 1.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 1.4 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 1.9 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 2.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 7.8 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 3.0 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 3.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 1.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 2.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 1.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 3.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 1.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 1.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 1.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.8 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.7 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 1.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 1.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 3.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 3.5 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.0 | 0.5 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 3.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 1.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 1.1 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |